NSE · KREBSBIO
Krebs Biochemicals and Industries Limited
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#2,800
of 5,072 stocks
▼ 41W
Peak #2,796 · 21 Sep 2026
A microcap name in Healthcare, Krebs Biochemicals and Industries Limited is seeing revenue contract sharply, remains firmly promoter-controlled, with promoters holding 73%, and posts a modest return on equity.
Market Cap
122.77 Cr
P/E Ratio
—
P/B Ratio
—
ROE
10.40%
ROCE
-19.62%
Dividend Yield
—
52W High
—
52W Low
—
Quarterly financials
| Metric | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 | Q2 2025-26 |
|---|---|---|---|---|
| Revenue | 6.98 Cr | 6.81 Cr | 7.27 Cr | 4.17 Cr |
| Net Profit | -2.48 Cr | -2.34 Cr | -3.13 Cr | -6.14 Cr |
| EPS | -1.15 | -1.09 | -1.45 | -2.85 |
| Operating Profit | -60.43 L | -42.96 L | -1.33 Cr | -4.41 Cr |
Shareholding pattern
Promoter
72.74%
Public
27.26%
Mutual fund holdings
Mutual fund holdings data for this stock hasn't been ingested yet — check back soon.
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 20 Sep 2023 | Other | Annual General Meeting |
| 15 Sep 2021 | Other | Annual General Meeting |
| 16 Sep 2020 | Other | Annual General Meeting |
| 13 Sep 2019 | Other | Annual General Meeting |
| 31 Jan 2019 | Rights | Rights 21:100 @ Premium Rs 76 Per Share |
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.